Corcoran Andrea

CIK 00012969963 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001296996

Recent Transactions

23 trades

Tax Payment
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2026-01-31$4.24/sh−16,104→ 763,576 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2026-01-31−44,366→ 0 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2026-01-31−10,500→ 0 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2026-01-31+180,000→ 180,000 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2026-01-31+54,866→ 779,680 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2025-01-31+200,000→ 200,000 total
Tax Payment
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-01-31$3.06/sh−16,102→ 717,307 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2025-01-31−44,367→ 44,366 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-01-31+10,500→ 733,409 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2025-01-31+10,500→ 10,500 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-01-31+44,367→ 722,909 total
Sale
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2024-02-01$3.84/sh−15,843→ 670,208 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2024-01-31−44,367→ 88,733 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2024-01-31+44,367→ 686,051 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2024-01-31+200,000→ 200,000 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2023-01-31+133,100→ 133,100 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2023-01-31+186,300→ 186,300 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2022-01-31+181,000→ 181,000 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2021-01-29+148,850→ 148,850 total
Conversion
Atea Pharmaceuticals, Inc.$AVIR
Series B Convertible Preferred Stock
2020-11-03−33,004→ 0 total
Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2020-11-03+133,004→ 633,004 total
Conversion
Atea Pharmaceuticals, Inc.$AVIR
Series A Convertible Preferred Stock
2020-11-03−100,000→ 0 total
Award
IDENIX PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2005-02-28+30,000→ 30,000 total

Companies

Recent Filings

Address

225 FRANKLIN STREET SUITE 2100

BOSTON, MA, 02110

View on SEC.gov